Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Pons

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Journal of Molecular Biology|May 1, 2012
Generating bispecific human IgG1 and IgG2 antibodies from any antibody pairPavel Strop, Wei-Hsien Ho, Leila M Boustany, et al.
The Lancet. Oncology|November 18, 2021
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion studyNehal J Lakhani, Laura Q M Chow, Justin F Gainor, et al.
International Journal of Molecular Sciences|April 27, 2024
Phenotypic Expression and Outcomes in Patients with the p.Arg301Gln <i>GLA</i> Variant in Anderson-Fabry DiseaseRocío Blanco, Yolanda Rico-Ramírez, Álvaro Hermida-Ameijeiras, et al.
Scientific Reports|August 13, 2025
Genetic testing and evidence of a founder mutation in a hotspot for hereditary transthyretin amyloidosisMarc Ventayol-Guirado, Eugenia Cisneros-Barroso, Maria Antonia Ribot-Sanso, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 21, 2025
Revisiting the genetic epidemiology of ATTRv in Spain: the Balearic Islands as a high-prevalence founder focusMarc Ventayol-Guirado, Eugenia Cisneros-Barroso, Maria Antonia Ribot-Sansó, et al.
Chemistry & Biology|February 27, 2013
Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugatesPavel Strop, Shu-Hui Liu, Magdalena Dorywalska, et al.
Cell Host & Microbe|July 2, 2014
Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangementsKatherine J L Jackson, Yi Liu, Krishna M Roskin, et al.
Nature Medicine|January 14, 2022
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradicationJohanna Theruvath, Marie Menard, Benjamin A H Smith, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 27, 2023
Vaccine-carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccinationPablo Pastor Pueyo, Elena Gambó Ruberte, Jara Gayán Ordás, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal of Molecular Biology|May 1, 2012
Generating bispecific human IgG1 and IgG2 antibodies from any antibody pairPavel Strop, Wei-Hsien Ho, Leila M Boustany, et al.
The Lancet. Oncology|November 18, 2021
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion studyNehal J Lakhani, Laura Q M Chow, Justin F Gainor, et al.
International Journal of Molecular Sciences|April 27, 2024
Phenotypic Expression and Outcomes in Patients with the p.Arg301Gln <i>GLA</i> Variant in Anderson-Fabry DiseaseRocío Blanco, Yolanda Rico-Ramírez, Álvaro Hermida-Ameijeiras, et al.
Scientific Reports|August 13, 2025
Genetic testing and evidence of a founder mutation in a hotspot for hereditary transthyretin amyloidosisMarc Ventayol-Guirado, Eugenia Cisneros-Barroso, Maria Antonia Ribot-Sanso, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|October 21, 2025
Revisiting the genetic epidemiology of ATTRv in Spain: the Balearic Islands as a high-prevalence founder focusMarc Ventayol-Guirado, Eugenia Cisneros-Barroso, Maria Antonia Ribot-Sansó, et al.
Chemistry & Biology|February 27, 2013
Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugatesPavel Strop, Shu-Hui Liu, Magdalena Dorywalska, et al.
Cell Host & Microbe|July 2, 2014
Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangementsKatherine J L Jackson, Yi Liu, Krishna M Roskin, et al.
Nature Medicine|January 14, 2022
Anti-GD2 synergizes with CD47 blockade to mediate tumor eradicationJohanna Theruvath, Marie Menard, Benjamin A H Smith, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 27, 2023
Vaccine-carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccinationPablo Pastor Pueyo, Elena Gambó Ruberte, Jara Gayán Ordás, et al.
Pageof 9